First Time Loading...

Cosmos Pharmaceutical Corp
TSE:3349

Watchlist Manager
Cosmos Pharmaceutical Corp Logo
Cosmos Pharmaceutical Corp
TSE:3349
Watchlist
Price: 14 700 JPY 0.93% Market Closed
Updated: May 6, 2024

Cosmos Pharmaceutical Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cosmos Pharmaceutical Corp
Operating Income Peer Comparison

Comparables:
9989
3391
3141
S
7649
3088

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Cosmos Pharmaceutical Corp
TSE:3349
Operating Income
¥30.6B
CAGR 3-Years
-5%
CAGR 5-Years
4%
CAGR 10-Years
6%
Sundrug Co Ltd
TSE:9989
Operating Income
¥41.2B
CAGR 3-Years
2%
CAGR 5-Years
3%
CAGR 10-Years
4%
Tsuruha Holdings Inc
TSE:3391
Operating Income
¥48.1B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
8%
Welcia Holdings Co Ltd
TSE:3141
Operating Income
¥45.3B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
13%
S
Sugi Holdings Co Ltd
TSE:7649
Operating Income
¥36.6B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
6%
MatsukiyoCocokara & Co
TSE:3088
Operating Income
¥72.7B
CAGR 3-Years
29%
CAGR 5-Years
15%
CAGR 10-Years
13%

See Also

What is Cosmos Pharmaceutical Corp's Operating Income?
Operating Income
30.6B JPY

Based on the financial report for Nov 30, 2023, Cosmos Pharmaceutical Corp's Operating Income amounts to 30.6B JPY.

What is Cosmos Pharmaceutical Corp's Operating Income growth rate?
Operating Income CAGR 10Y
6%

Over the last year, the Operating Income growth was 1%. The average annual Operating Income growth rates for Cosmos Pharmaceutical Corp have been -5% over the past three years , 4% over the past five years , and 6% over the past ten years .